New potent HBV replication inhibitors for the management of chronic hepatitis B are needed.
Block TM, Guo JT, Zoulim F, Rice CM, Thio CL, Schneider WM, Alter HJ, Jacobson IM, Gish RG, Block PD, Sulkowski M, Feld JJ, Cohen CA.
Block TM, et al. Among authors: block pd.
Nat Rev Gastroenterol Hepatol. 2025 Mar;22(3):150-151. doi: 10.1038/s41575-025-01037-z.
Nat Rev Gastroenterol Hepatol. 2025.
PMID: 39910374
No abstract available.